Noticias de ATOS_US
Noticias del mercado
Últimas noticias sobre ATOS_US — 117 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Atossa reports breast density reduction in endoxifen trial
Atossa reports breast density reduction in endoxifen trial By Investing.com
/PRNewswire/ -- Atossa Therapeutics, Inc. (Atossa o la compañía) (Nasdaq: ATOS), una compañía biofarmacéutica en etapa clínica centrada en el desarrollo de novedosos...
Atossa Therapeutics Announces Publication of KARISMA Endoxifen Trial Demonstrating Significant Reduction in Mammographic Breast Density in Healthy Premenopausal Women
Atossa Genetics stock surges after FDA rare disease designation By Investing.com
Atossa gets rare pediatric disease tag for endoxifen in MAS By Investing.com
FDA awards Atossa Therapeutics rare pediatric designation for Z-endoxifen milestone
Atossa Therapeutics (ATOS) Secures FDA Designation for Pediatric Treatment
Atossa gets rare pediatric disease tag for endoxifen in MAS By Investing.com
Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for McCune-Albright Syndrome
Página 3 de 6
